跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 176 条关于
“OneChain Immunotherapeutics”
全部
176
临床试验
40
药物
40
机构
12
资讯
84
2年前
Pharmaceutical Industry Leadership Shuffle: Major Executive Appointments Signal Strategic Shifts Across Biotech and Pharma
去年
MoonLake Immunotherapeutics Reports Progress on Sonelokimab and Financial Results in Q3 2024
去年
OSE Immunotherapeutics Announces Positive H1 2024 Results and Corporate Updates
去年
OSE Immunotherapeutics Advances Global Phase 3 Trial for Cancer Vaccine Tedopi
去年
MoonLake Immunotherapeutics Initiates Phase 3 Program for Sonelokimab in Psoriatic Arthritis
去年
Lusvertikimab Shows Promise in Ulcerative Colitis Phase 2 Trial
去年
Merck Explores $3+ Billion Acquisition of Swiss Biotech MoonLake Immunotherapeutics
去年
MoonLake Immunotherapeutics Affirmed with Buy Rating for Strategic Clinical Expansion
去年
OSE Immunotherapeutics and AbbVie Partner on Novel Anti-Inflammatory Program in $713M Deal
9个月前
OSE Immunotherapeutics Regains Control of ABBV-230 Early Development in Strategic Partnership Amendment with AbbVie
第 1 页,共 9 页
上一页
下一页